- AdventHealth
American College of Lifestyle Medicine (ACLM) presented George Guthrie, M.D. with the 2022 President’s Award for his exceptional dedication to lifestyle medicine during the organization’s annual Lifestyle Medicine Conference.
A pioneer in the growing specialty of lifestyle medicine, Guthrie is a board-certified family medicine physician and a member of the family medicine team at AdventHealth’s academic practice in Winter Park. His special interest is in lifestyle management for those with Type 2 diabetes, hypertension, obesity and coronary heart disease.
Additionally, he trains family medicine residents with an emphasis on lifestyle medicine and has been involved with the piloting and development of AdventHealth’s Complete Health Improvement Project (CHIP), the Wellspring Diabetes Program, and the CREATION Life program.
“The growth of lifestyle medicine research over the last 40 years and its acceptance by physicians is encouraging,” said Guthrie. “As clinicians become aware of the research and make it available for their patients, medicine is slowly changing for the better.”
For example, Guthrie said, the American Diabetes Association recently published a paper on what criteria satisfies the status of Type 2 diabetes in remissions.
Additionally, Guthrie added, while the medical community has known since the early 1990s that heart disease is reversible, the Centers for Medicare and Medicaid Services now pays for heart disease reversal programs like Ornish and Pritikan.
A founding member of ACLM, Guthrie previously served as secretary-treasurer and president. Under his leadership, the organization flourished, growing from a few hundred members to more than 9,000 members today with a now generous budget that allows for innovative special projects.
“Dr. Guthrie recognized the potential for evidence-based lifestyle medicine to treat chronic disease early on and has worked tirelessly to put lifestyle medicine at the center of all health and health care,” said ACLM Past President Cate Collings, M.D. “His leadership of ACLM helped spark the transformation of what at the time was still a fledging medical professional society into the dynamic organization that it is today. We are grateful to Dr. Guthrie for his passion and service.”
“It was a pleasure to be honored along with Jack LaLane (now deceased and represented by his wife) and Dr. Kenneth Cooper for their work in lifestyle medicine,” said Guthrie. “I personally appreciate the support of AdventHealth through my years as a leader in this illustrious organization.”
Guthrie has authored several books, including “Eat Plants Feel Whole,” and its corresponding journal as well as cookbook of the same name,” Plant Powered Recipes to Help You Feel Whole.” He played an instrumental role in the development of the film, PlantWise.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...